Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1997 Jun;34(6):525–526. doi: 10.1136/jmg.34.6.525

Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.

S Sohda 1, T Arinami 1, H Hamada 1, N Yamada 1, H Hamaguchi 1, T Kubo 1
PMCID: PMC1050983  PMID: 9192280

Abstract

A common missense mutation in the methylenetetrahydrofolate reductase (MTHFR) gene, a C to T substitution at nucleotide 677, is responsible for reduced MTHFR activity and associated with modestly increased plasma homocysteine concentrations. Since underlying maternal vascular disease increases the risk of pre-eclampsia, we had the working hypothesis that pre-eclampsia patients would have an increased T677 allele frequency compared with controls. The MTHFR genotypes were determined in 67 pre-eclampsia patients, 98 normal pregnant women, and 260 healthy adults by the PCR/RFLP method. The T677 allele and the genotype homozygous for the T677 allele were significantly increased in the pre-eclamptic group compared with the controls (p < 0.02 and p < 0.004, respectively). The data indicate that the T677 variant of the MTHFR gene is one of the genetic risk factors for pre-eclampsia.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dekker G. A., de Vries J. I., Doelitzsch P. M., Huijgens P. C., von Blomberg B. M., Jakobs C., van Geijn H. P. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 1995 Oct;173(4):1042–1048. doi: 10.1016/0002-9378(95)91324-6. [DOI] [PubMed] [Google Scholar]
  2. Frosst P., Blom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., Boers G. J., den Heijer M., Kluijtmans L. A., van den Heuvel L. P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 May;10(1):111–113. doi: 10.1038/ng0595-111. [DOI] [PubMed] [Google Scholar]
  3. Steegers-Theunissen R. P., Boers G. H., Blom H. J., Trijbels F. J., Eskes T. K. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet. 1992 May 2;339(8801):1122–1123. doi: 10.1016/0140-6736(92)90725-i. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES